Sanjay K. Jain, MD

We have gained recognition for pioneering molecular imaging technologies for infectious diseases, leading to novel ways of studying pathogenesis, diagnosis and monitoring of infections, and precision medicine approaches for patients with complicated infections. We have expertise in bacterial and fungal infections as well as and high-containment pathogens such as Mycobacterium tuberculosis (causative agent of tuberculosis). My laboratory utilizes small animal models and cutting-edge molecular imaging technologies (CT, PET, SPECT, MRI) to study disease pathogenesis as well as to develop precision medicine tools for patients. I am leading several first-in-human studies for novel imaging agents developed in my laboratory. I have several active NIH grants, and >140 peer-reviewed publications, many in high impact journals, co-authored with my trainees.

I am also involved with training the next generation of physicians, scientists and physician-scientists. From 2014 to 2022, I directed the Johns Hopkins ACGME-accredited Pediatric Infectious Diseases Fellowship Program. I was co-director (2018–2021) and then director and PI (2021–2025) of the NIH T32-AI052071 training grant that supported the Pediatric Infectious Diseases Fellowship program at Johns Hopkins.

I am funded through several NIH and other grants. Notably, I am also the recipient of the prestigious NIH Director’s New Innovator Award (2009) and the NIH Director’s Transformative Research Award (2014). I am the founding member and past chair, Infectious Diseases subgroup (2013–2021) and board of trustees of the World Molecular Imaging Society (2021–2025). I serve as a reviewer for multiple scientific journals and NIH study panels.